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Abstract
Background: Due to the prevalence of the westernized dietary pattern and lack of physical activity, the numbers of overweight
or obese individuals are increasing, resulting in a growing health burden because of various related diseases. A lifestyle modification
approach has additional advantages compared with pharmacological therapies or bariatric surgery. In our randomized controlled
trial conducted in 2015, we successfully used a ubiquitous health care (SmartCare) service for patients with metabolic syndrome
to achieve a significant weight loss effect. Various useful apps have been developed for the SmartCare Service, which involves
using a mobile phone to manage chronic diseases, minimizing time and space restrictions. Many studies have demonstrated weight
loss effects using a SmartCare service, but limited data are available regarding the effect of active participation in relation to
weight loss.
Objective: We aimed to assess the weight loss effect achieved after using the SmartCare service in terms of adherence and
participation. We divided the intervention group of the previous study according to participation level, and analyzed whether
there was a significant difference in the outcome.
Methods: We classified participants into 3 groups according to their adherence. Within the intervention group using the SmartCare
service, the active group comprised those transmitting anthropometric measurement data using a mobile phone 3 or more times
per week or who had a health consultation 5 or more times during a 24-week period. The passive group comprised those who did
not adhere to these levels of engagement. The control group comprised those who did not use the SmartCare service. We compared
changes in body weight, body mass index (BMI), body fat percentage, waist circumference, and lipid profile among the 3 groups.
Results: We identified 422 participants and analyzed 405, excluding 17 who were missing necessary data for analysis. The
active group consisted of 116 participants, compared with 80 in the passive group and 209 in the control group (without SmartCare
service). There was a statistically significant difference in improvements to body weight, BMI, body fat percentage, and waist
circumference among active participants compared with less active participants and the control group (P<.05). However, the lipid
profile changes did not differ significantly between groups.
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Conclusions: The level of participation may be related to improved weight-related outcomes, which may improve health
outcomes. To maximize the effectiveness of the SmartCare service, encouraging active participation is important.
Trial Registration: Clinicaltrials.gov NCT01344811; https://clinicaltrials.gov/ct2/show/NCT01344811 (Archived by WebCite
at http://www.webcitation.org/6alT2MmIB)
(JMIR Mhealth Uhealth 2018;6(1):e2)   doi:10.2196/mhealth.8719
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Introduction
Being overweight or obese increases the risk of cardiovascular
disease, diabetes, cancer, and musculoskeletal disorders,
resulting in approximately 3 million deaths worldwide each
year [1]. Westernized dietary patterns and a lack of physical
activity are considered to be the primary causes. According to
the Korea National Health and Nutrition Examination Surveys,
the prevalence of obesity in Korean adults was 32.0% in 2011,
which was much higher than the 26.9% recorded in 1998 [2].
Therefore, it is important to manage and treat obesity, and it is
essential to improve eating and exercise habits before
considering medication or surgical treatment options [3].
However, because lifestyle modifications need continuous
monitoring and feedback in everyday life, patients can find these
modifications difficult and burdensome [4]. An important issue
concerns how best to overcome the difficulties in adhering to
lifestyle modifications.
Koreans have the highest level of smartphone ownership in the
world, and smartphone penetration rate reached 79.5% in 2012
[5]. Recently, the use of a ubiquitous health care (SmartCare)
service, equipped with advanced technology for the health care
of chronically ill patients with hypertension and diabetes, has
been rapidly growing [6]. Numerous studies have revealed that
a mobile phone can be used as a strategic tool for weight
management in obese patients [7-9]. Unlike desktop computers,
a mobile phone provides mobility to users, and also includes
sensors such as global positioning systems and acceleration
sensors, as well as being applicable to various mobile health
care services. It is also possible to access the Internet easily
without time and space restrictions, thus enabling real-time
one-on-one consultation and communication with health care
experts.
Previously, we conducted a randomized controlled trial to
evaluate the effect of a SmartCare service on weight
management in obese patients with metabolic syndrome
(NCT01344811) [10]. Among adults over 20 years of age who
visited Seoul National University Hospital or the Severance
Hospital, both in Seoul, South Korea, obese patients with
metabolic syndrome were identified for possible inclusion in
this study. The prevalence of metabolic syndrome in Korean
adults continues to increase, which increases cardiovascular
morbidity and mortality and all-cause mortality [11-13].
That study was, to our knowledge, the first government-funded
project in Korea undertaken to estimate the usefulness of a
SmartCare service in managing chronic disease. It concluded
that weight control using the SmartCare service was significantly
better than for a control group using conventional methods.
However, the effect of adherence to the SmartCare service has
not been analyzed among participants.
Recent studies related to mobile health care services have
focused primarily on comparing information and communication
technology intervention efficacy between users and nonusers,
so there is little research on whether adherence and weight loss
outcomes are positively correlated. The purpose of this study
was to clarify the relationship between adherence and weight
loss outcomes through further analysis of our previous study.
Prior to the study, we hypothesized that a higher level of
participation would produce a better outcome, and we attempted
to set criteria for intensive participation. As family medical
practitioners involved in patient education, we aimed not only
to recommend the SmartCare service, but also to provide
effective participation criteria.
Methods
Recruitment
We advertised our study using institutional review board
(IRB)-approved banners, posters, and leaflets placed in the
hospitals’ lobbies.
According to the Adult Treatment Panel III criteria, using waist
circumference cutoff modifications for Asian populations as
suggested in the Asia-Pacific guidelines, we defined metabolic
syndrome as having 3 or more of the following factors [14]: (1)
central obesity: waist circumference 90 cm or more in men and
80 cm or more in women; (2) hypertriglyceridemia: triglyceride
8.325 mmol/L or more; (3) high-density lipoprotein (HDL)
cholesterol less than 2.22 mmol/L in men and less than 2.775
mmol/L in women; (4) hypertension: blood pressure 130/85
mmHg or more, or taking antihypertensive medication; and (5)
hyperglycemia: fasting glucose 5.55 mmol/L or more, or taking
antidiabetic medication.
The World Health Organization Western Pacific Region
recommends defining obesity in Asian populations as those
individuals with a body mass index (BMI) 25 kg/m2 or greater
[15]. The Korean Society for the Study of Obesity also
investigated BMI cutoff figures for obesity-related disease and
adopted the World Health Organization’s definition. Nowadays,
Korean government organizations officially use this definition
when defining and implementing health policies regarding
obesity in Korea [16].
However, we excluded from this study individuals taking thyroid
hormone or antiobesity medication, which can affect weight,
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along with patients with insulin-dependent diabetes with liver
functional abnormality (with a liver somatic index over 3 times
higher than the normal maximum level) or with renal functional
impairment (with a creatinine level over one and a half times
higher than the normal maximum level), pregnant women, and
inpatients.
We assigned eligible participants to 2 groups, with equal
probability, according to a randomization code. The
randomization code was prepared using a block randomization
method, stratified by a statistician in a clinical trial center (C&R
Research, Seoul, South Korea). As this study was an open-label
trial, blinding was not undertaken.
The IRB of Seoul National University Hospital approved this
study (IRB number: h-1009-095-333).
Intervention Using a SmartCare Service
We randomly allocated participants into 2 groups. The
intervention group was provided with a mobile phone equipped
with a SmartCare app, a body composition meter (InBody
IH-U070B, InBody Co Ltd, Seoul, South Korea) with Bluetooth
function, and a pedometer (MP-100, Yamasa Co, Ltd, Okayama,
Japan).
Each participant measured his or her own body weight and body
composition (skeletal muscle mass, fat mass) using the provided
body composition monitor at the same hour every day, if
possible (or at least 3 times a week), after waking up and before
breakfast. After measuring the relevant values with the body
composition monitor, the participants placed the transmission
terminal (Bluetooth) of the remote monitoring device near the
transmission terminal of the mobile phone to transmit the
measurement data to the central server in the SmartCare center
via mobile phone (wireless network). Each participant carried
a pedometer on the waist from the time they woke until the time
they went to bed. Participants checked their activity level,
indicated as the number of steps taken, at the same time every
day, if possible, and entered this into the mobile phone (data
entry before going to bed was recommended). The entered data
were then automatically transmitted to the central server in the
SmartCare Center. Physicians or health care personnel at the
SmartCare Center could retrieve hospital admission information,
treatment records, diagnosed diseases identification, diagnostic
examinations and functional test results, and prescription
information of the test participants through connecting to the
hospital information system, with participant consent. The
central server in the SmartCare Center transmitted the feedback,
based on the measured body weight and body composition, to
the mobile phones of the participants, according to the algorithm
of the clinical decision support system. The participants were
able to immediately check the interpretations and
recommendations, based on their measured values, through their
mobile phones.
Trained consultants (nurses, exercise specialists, and clinical
dietitians) at the SmartCare Center undertook various health
consultations through the patients’ telephone inquiries
concerning disease management, health education,
recommended exercise, medication, and appropriate nutrition.
Monthly and weekly health reports, based on the individual
patient’s measured values and daily living records, were sent
directly to the patients through the SmartCare system.
Additionally, in instances where medical treatment was received
at Seoul National University Hospital or the Severance Hospital,
the physician providing the medical care had access to the
information (Figure 1).
Figure 1. Model of SmartCare service.
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Comparison Group
We provided the comparison group only with anthropometric
instruments and pedometers.
We provided body weight scales and pedometers to the
participants assigned to the control group. Body weight journals
were distributed to the participants, and each participant
self-measured and recorded his or her daily weight and waist
size (a minimum of 3 times per week) at the same time (before
breakfast). They also wore a pedometer during daily activities,
which started from the time they woke in the morning until
bedtime. They were instructed to check and record their daily
walking distances on the record sheet just before going to bed.
Additionally, the participants in the control group had the same
hospital visit schedule as that of the intervention group at 12-
and 24-week intervals, and received anthropometry,
consultations with physicians, and information about their
nutrition and exercise.
As with the intervention group, individual health care counseling
services were provided, but only at the hospital.
As an incentive for registering as study participants for both the
intervention and comparison groups, the Korean Ministry of
Commerce, Industry and Energy national project budget covered
all expenses for medical treatment, medication, transportation,
and communication (mobile phone provision and use).
Study Design
We requested the participants to visit the hospitals 4 times during
the 24-week period. Except when screening was performed,
body weight, body composition, and blood pressure
measurements were recorded. A hematology test was performed,
and changes in their life habits (eg, diet intake and physical
activity) were recorded 3 times during the test period: once on
the date of random allocation, once in week 12, and once in
week 24 (Figure 2).
Analysis consisted of 2 group sets: intention-to-treat (ITT) and
per protocol. The ITT set included all participants who were
enrolled in this clinical trial and were randomly allocated. When
analyzing efficacy, we included participants in the treatment
group to which they had been randomly allocated, regardless
of the actual treatment they received. Among the participants
in the ITT set, we included those who completed this clinical
trial without a material breach of the protocol in the per protocol
set (Figure 3).
Additional Analysis According to Medical Adherence
We classified the intervention group into an active participation
group and a passive participation group, according to adherence.
The definition of adherence was divided into 2 parts as follows:
(1) measurement of anthropometric data and input of pedometer
data directly into the mobile phone 3 or more times a week, and
(2) taking part in a health consultation 5 or more times during
a 24-week period.
Figure 2. Flowchart of the intervention.
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Figure 3. Selection of the study participants. ITT: intention-to-treat; PP: per protocol.
Measurement Variables
At the time of screening, demographic information (age, sex,
smoking, alcohol consumption, and other relevant information),
medical history, and medication history of the participants were
investigated and recorded. Additionally, an electrocardiogram
was recorded at the screening visit after the participant had been
resting for at least 5 minutes. When test results were clinically
significant, the investigator determined whether to enroll the
participant in the study.
Laboratory tests were conducted at screening, baseline, week
12, and week 24 for alanine aminotransferase, aspartate
aminotransferase, creatinine, lipid profile (total cholesterol,
HDL cholesterol, and triglyceride), fasting glucose, and
hemoglobin A1c. However, alanine aminotransferase, aspartate
aminotransferase, and creatinine tests were performed only at
screening to determine trial eligibility. Lipid profiles and blood
glucose tests were performed after the participant had been
fasting.
We evaluated weight change, the primary outcome, using body
fat percentage at baseline and at 12 and 24 weeks, as measured
by nurses using portable bioelectrical impedance analysis
(InBody U20, InBody Co Ltd).
We assessed and categorized the level of physical activity using
the International Physical Activity Questionnaire at baseline,
12 weeks, and 24 weeks. The amount of physical activity each
week was calculated with a continuous variable, namely the
metabolic equivalent task (MET), as follows: total METs
min/week = [walking METs × min × days] + [moderate METs
× min × days] + [vigorous METs × min × days]) [17].
For measuring caloric intake variables, daily meal record cards
(3-day recall dietary assessments) were distributed to the
participants during their initial visit, and the participants were
instructed to write their own 3-day meal record just before the
baseline visit, the next visit after 12 weeks, and the final visit
at 24 weeks. The self-completed daily meal records were
collected from the participants during their final visit, and
dietitians calculated caloric intake using the nutrient evaluation
program CAN-Pro 3.0 (The Korean Nutrition Society) [18].
Statistical Analysis
The effectiveness analysis comprised the ITT population, which
included all randomly allocated participants. We imputed
missing data using the last observation carried forward method.
We calculated descriptive statistics (number of observed
participants, mean [standard deviation (SD)], and median
[range]) on body weight measured at baseline and at the end
point (24 weeks), and the changes in measured values at week
24 compared with baseline for each group. To identify the
difference between the groups with respect to body weight
changes at week 24 compared with baseline, we used analysis
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of covariance (ANCOVA), with the clinical trial institution that
recruited participants and body weight at baseline as covariates.
For continuous data (changes in BMI, body fat percentage, waist
measurement, lipid profile, blood pressure, number of metabolic
syndrome elements, diet intake in kilocalories, physical activity,
number of steps taken, and weight to measure physical activity),
we determined descriptive statistics (number of observed
participants, mean [SD], and median range]) per group. To
identify the difference between the groups in the changes at
week 24 compared with baseline, we performed ANCOVA or
rank transformation ANCOVA. When conducting ANCOVA,
we set the clinical trial institution that recruited participants and
the baseline values of relevant parameters as covariates.
All analyses were conducted using SAS version 9.3 (SAS
Institute). All statistical tests were performed at a 2-sided
significance level of .05.
Results
Baseline Characteristics
We identified 422 patients able to use mobile phones, and who
were willing to participate in the study and sign informed
consent forms, for recruitment. All participants received the
SmartCare service, and we excluded from the final analysis 17
participants who did not enter any data for 24 weeks. Following
the definition of adherence already described, we used 2 criteria
for dividing the active and passive participation groups. First,
we analyzed the demographic characteristics according to the
number of weekly mean anthropometric measurements. Second,
we analyzed the data according to total counseling frequency,
age, sex, BMI, alcohol consumption, education level, and
smoking status did.
Efficacy Evaluation Summary
Changes in Anthropometric Data During the 24-Week
Period
First, we examined differences in characteristics according to
the weekly mean number of anthropometric measurements
(Figure 4).
Following classification according to self-reporting frequency,
there were 116 active participants and 80 less active participants
(Table 1). The average weight loss effect during the whole
period was greatest in the active participation group, lower in
the control group, and lowest in the less active participation
group. There was no statistically significant difference between
the control group and the less active participation group (Table
1). The mean change of body weight was –3.18 (SD 0.29) kg
in the active group, –0.70 (SD 0.35) kg in the less active group,
and –0.82 (SD 0.23) kg in the control group. BMI, body fat
percentage, and waist circumference were most enhanced for
those in the active participation group, less enhanced in the less
active participation group, and least enhanced in the control
group. In particular, there was no difference in body weight and
BMI at baseline between the active participant group and the
control group, but there was a statistically significant difference
in body weight, BMI, body fat percentage, and waist
circumference at the end of 24 weeks (Table 1).
Figure 4. Changes in anthropometric data during the 24-week period analyzed according to weekly mean number of anthropometric measurements.
Error bars indicate standard deviation. BMI: body mass index.
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Table 1. Demographic and other pretreatment characteristics (intention-to-treat set) by the weekly mean number of anthropometric measurements
(n=405).
Between-group P valueControl group (C)Intervention groupDemographic and other pretreatment
characteristics
B-CA-CA-B<3 times a week (B)≥3 times a week (A)
Age (years)
209 (51.6)80 (20.0)116 (28.6)Total, n (%)
<.001b.96b<.001b50.36 (14.27)42.11 (12.33)50.45 (12.24)Mean (SDa)
52.0041.5052.50Median
21.00-82.0020.00-72.0023.00-71.00Range
Range, n (%)
.001c.55c<.001c18 (8.6)14 (17.5)5 (4.3)20-29
40 (19.1)23 (28.8)21 (18.1)30-39
33 (15.8)20 (25.0)21 (18.1)40-49
61 (29.2)15 (18.8)40 (34.5)50-59
57 (27.3)8 (10.0)29 (25.0)≥60
Sex, n (%)
209 (51.6)80 (20.0)116 (28.6)Total
.31c.89c.42c101 (48.3)44 (55.0)57 (49.1)Male
108 (51.7)36 (45.0)59 (50.9)Female
Body mass index (kg/m2)
209 (51.6)80 (20.0)116 (28.6)Total, n (%)
.45b.1b.03b29.40 (3.39)29.72 (3.11)28.77 (3.09)Mean (SD)
28.9029.2028.00Median
24.90-41.8025.00-41.4024.90-41.00Range
Body weight (kg)
209 (51.6)80 (20.0)116 (28.6)Total, n (%)
.04b.15b.001b79.74 (15.28)83.86 (14.51)77.48 (12.30)Mean (SD)
76.9083.2076.60Median
54.00-141.1058.60-135.4055.20-128.50Range
Height (cm)
209 (51.6)80 (20.0)116 (28.6)Total, n (%)
.01b.78b.005b164.12 (10.61)167.49 (9.29)163.82 (8.73)Mean (SD)
163.00169.20165.00Median
142.80-189.00144.50-188.90146.00-182.00Range
Smoking status, n (%)
203 (51.6)80 (20.0)115 (28.4)Total
.65c.02c.02c129 (63.6)47 (58.8)72 (62.6)Nonsmoker
40 (19.7)16 (20.0)34 (29.6)Former smoker
34 (16.8)17 (21.3)9 (7.8)Smoker
Drinking status, n (%)
206 (51.6)80 (20.0)115 (28.4)Total
.03c.68c.01c84 (40.8)20 (25.0)51 (44.4)Nondrinker
15 (7.3)5 (6.3)10 (8.7)Former drinker
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Between-group P valueControl group (C)Intervention groupDemographic and other pretreatment
characteristics
B-CA-CA-B<3 times a week (B)≥3 times a week (A)
107 (51.9)55 (68.8)54 (47.0)Drinker
Completed education level, n (%)
209 (51.6)80 (20.0)116 (28.6)Total
.001d.15c.11d21 (10.2)04 (3.5)Elementary school
15 (7.2)3 (3.85)6 (5.2)Middle school
65 (31.1)19 (23.8)39 (33.6)High school
108 (51.7)58 (72.5)67 (57.8)University
aSD: standard deviation
b2-sample t test.
cPearson chi-square test.
dFisher exact test.
Second, we examined differences in characteristics according
to the total number of health consultations (Figure 5).
Following classification according to the total number of health
consultations, there were 98 active participants and 98 less active
participants (Table 2). Weight, BMI, body fat percentage, and
waist circumference were highest in the active participation
group, lower in the less active participation group, and lowest
in the control group. The mean change of body weight was
–2.81 (SD 0.32 kg in the active group, –1.54 (SD 0.32) kg in
the less active group, and –0.81 (SD 0.24) kg in the control
group. In addition, improvements in body weight, BMI, body
fat percentage, and waist circumference differed significantly
between the active and the less active participation groups. Even
where participants received the same SmartCare service, it was
clear that the outcome depended on the participation level (Table
2).
Changes in Biomarker (Lipid Panel) During the 24-Week
Period
When we analyzed biomarkers according to the weekly mean
number of anthropometric measurements and the total number
of health consultations, we found no statistically significant
differences between groups (data not shown).
Figure 5. Changes in anthropometric data during the 24-week period analyzed according to total number of health consultations. Error bars indicate
standard deviation. BMI: body mass index.
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Table 2. Demographic and other pretreatment characteristics (intention-to-treat set) by total number of health consultations (n=405).
Between-group P valueControl group (C)Intervention groupDemographic and other pretreatment
characteristics
B-CA-CA-B<5 times in total period (B)≥5 times in total period (A)
Age (years)
209 (51.6)98 (24.2)98 (24.2)Total, n (%)
.001b.59b.009b50.36 (14.27)44.64 (13.14)49.45 (12.29)Mean (SDa)
52.0044.0050.50Median
21.00-82.0020.00-71.0023.00-72.00Range
Range, n (%)
.07c.67c.17c18 (8.6)13 (13.3)6 (6.1)20-29
40 (19.1)25 (25.5)19 (19.4)30-39
33 (15.8)22 (22.5)19 (19.4)40-49
61 (29.2)22 (22.5)33 (33.7)50-59
57 (27.3)16 (16.3)21 (21.4)≥60
Sex, n (%)
209 (51.6)98 (24.2)98 (24.2)Total
.91c.35c.48c101 (48.3)48 (49.0)53 (54.1)Male
108 (51.7)50 (51.0)45 (45.9)Female
Body mass index (kg/m2)
209 (51.6)98 (24.2)98 (24.2)Total, n (%)
.8b.16b.13b29.40 (3.39)29.50 (2.93)28.82 (3.30)Mean (SD)
28.9029.0028.00Median
24.90-41.8024.90-37.9025.00-41.40Range
Body weight (kg)
209 (51.6)98 (24.2)98 (24.2)Total, n (%)
.46b.68b.26b79.74 (15.28)81.17 (13.30)79.00 (13.83)Mean (SD)
76.9080.9577.25Median
54.00-141.1055.50-135.4055.20-128.50Range
Height (cm)
209 (51.6)98 (24.2)98 (24.2)Total, n (%)
.28b.36b.82b164.12 (10.61)165.47 (9.48)165.17 (8.79)Mean (SD)
163.00165.35167.00Median
142.80-189.00148.00-188.90144.50-181.00Range
Smoking status, n (%)
203 (51.6)97 (24.2)98 (24.2)Total
.87c.01c.01c129 (63.6)62 (63.9)57 (58.2)Nonsmoker
40 (19.7)17 (17.5)33 (33.7)Former smoker
34 (16.8)18 (18.6)8 (8.2)Smoker
Drinking status, n (%)
206 (51.6)97 (24.2)98 (24.2)Total
.72c.41c.36c84 (40.8)38 (39.2)33 (33.7)Nondrinker
15 (7.3)5 (5.2)10 (10.2)Former drinker
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Between-group P valueControl group (C)Intervention groupDemographic and other pretreatment
characteristics
B-CA-CA-B<5 times in total period (B)≥5 times in total period (A)
107 (51.9)54 (55.7)55 (56.1)Drinker
Completed education level, n (%)
209 (51.6)98 (24.2)98 (24.2)Total
.04d.02c.37d21 (10.1)3 (3.1)1 (1.0)Elementary school
15 (7.2)5 (5.1)4 (4.1)Middle school
65 (31.1)24 (24.5)34 (34.7)High school
108 (51.7)66 (67.4)59 (60.2)University
aSD: standard deviation
b2-sample t test.
cPearson chi-square test.
dFisher exact test.
Discussion
Principal Findings
One previous study found that self-monitoring of body weight
in the workplace had a preventive effect on weight gain [19].
That study concluded that just increasing the self-measurement
frequency of body weight had a preventive effect, that is, weight
management improved through measurement adherence. For
this reason, we wanted to identify the cutoff value of adherence,
given that people with better adherence during the 24-week
study period had a better outcome. As a measure of participation,
we identified the weekly mean number of anthropometric
measurements and the total number of health consultations. As
we had hypothesized, the higher the participation, the greater
the improvement in anthropometric measurements.
The high frequency of physical measurement and consultation
frequency indicates that there was a strong willingness among
participants to manage their obesity.
Health care information technology (IT), also referred to as
medical IT, encompasses the process of storing, analyzing, and
delivering information, data, and knowledge from all activities
related to health care, using information processing technology
and networks. Demand is rapidly increasing in line with
developments in areas of medical care, such as population aging,
early diagnosis and treatment of diseases, and preventive
medicine. The medical IT convergence technologies that are
being actively developed in Korea include home care, using a
blood pressure monitor and blood glucose meter; home health
care, using a mobile phone to measure and transmit biometric
information to a service center; and wearable health care,
involving a wearable biosignal measurement system [20].
Many studies have already demonstrated the utility of managing
chronic diseases and obesity through health care programs that
use IT [21-26]. However, because programs are implemented
outside the hospital, continuous monitoring is needed to
encourage active participation, and it is important to inform
patients that the higher the participation, the better the health
improvement.
Comparison With Prior Research
Many studies have shown that close adherence to medical
treatment, or to lifestyle modification, results in a favorable
outcome [27-29]. Mobile phone health care is a new strategic
tool for chronic disease management, and numerous studies
have demonstrated the effectiveness of mobile phone health
care. However, our hypothesis was that active participation
would maximize the effects of mobile phone health care, about
which there has been little previous research. In our study, we
defined adherence as measuring anthropometric data 3 or more
times a week, or taking part in voluntary health consultations
at least 5 times in 24 weeks. However, the definition of
adherence can vary [30-32]. Further studies should be conducted
to demonstrate the relevance of adherence and the effectiveness
of mobile health care.
Limitations and Strengths
Concerning the lipid profile, although participation in the
SmartCare service was high, the improvement effect was not
significant. Previous studies have attempted to improve patients’
lipid profile through lifestyle modification, and these studies
have usually involved following the changing pattern of
biomarkers from 3 months to 5 years [33,34]. It is possible that
the 24-week period set in this study was not sufficient to show
changes in lipid profiles. Another plausible reason for the
reduced improvement in lipid profiles is that the intervention
to improve dietary habits was not appropriately targeted. A more
active intervention in respect of eating habits could also improve
biomarkers, including lipid profiles.
Although there was no statistically significant difference, all
total cholesterol, low-density lipoprotein cholesterol, HDL
cholesterol, and triglyceride levels tended to decrease. We found
that changes in HDL cholesterol and triglyceride levels, both
of which are key factors of metabolic syndrome, were close to
a P value of .05, although not significant, demonstrating that
the SmartCare service may be able to help patients with
metabolic syndrome make effective lifestyle modifications.
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Conclusions
Through initial and subsequent studies, we conclude that using
the SmartCare service is an effective way to control the weight
of obese patients with metabolic syndrome.
In addition, the improvement effect depended on adherence,
defined as entering anthropometric information 3 or more times
a week or participating in voluntary health consultations at least
5 times in 24 weeks.
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